Head-to-head · WeighScore
Chronos Body Health & Wellness vs Eden
The verdict
Eden takes it — 81.6/100 to 58.4/100.
Eden grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Chronos Body Health & Wellness | Eden |
|---|---|---|
| WeighScore | 58.4/100 | 81.6/100 |
| Grade | C | B− |
| Site position | #423 | #16 |
| Semaglutide | Not disclosed | Advertised $99/mo bundle; linked membership terms conflict—confirm checkout |
| Tirzepatide | Not disclosed | Advertised $129/mo bundle; linked membership terms conflict—confirm checkout |
| Coverage | 2 states | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #423 · C
Strengths
- Physician-led clinic with a named team — physicians, NPs and registered nurses
- Offers brand-name (Wegovy, Ozempic, Zepbound, Mounjaro) and compounded options
- No upfront payment — you start with a registered nurse consult
- Microdosing GLP-1 approach available for longer-term use
What to consider
- Telehealth only in Louisiana and Texas — not nationwide
- No upfront pricing published; cost depends on the plan after consult
- Compounded options prescribed only when medically appropriate
- Broader aesthetic/clinic focus, not a GLP-1-only specialist
Site position #16 · B−
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Strengths
- Current compounded offer includes medication and support
- Homepage also advertises branded prescription pathways; eligibility and cost require confirmation
- Named pharmacy operation and partner network can be investigated
What to consider
- Linked membership terms describe a separate fee model
- Landing-page warranty and terms use different thresholds and conditions
- FDA warning history remains relevant; a new offer does not establish resolution
Featured provider
Eden
Eden scores 81.6/100 (B−). Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.